Association of Interstage Home Monitoring With Mortality, Readmissions, and Weight Gain. Issue 6 (11th August 2015)

• Record Type: Journal Article
• Authors: Oster, Matthew E.; Ehrlich, Alexandra; King, Eileen; Petit, Christopher J.; Clabby, Martha; Smith, Sherry; Glanville, Michelle; Anderson, Jeffrey; Darbie, Lynn; Beekman, Robert H.
• Is Part Of: Circulation. Volume 132:Issue 6(2015)
• Publication Date: 2015-08-11
• Subjects: Blood -- Circulation -- Periodicals; Cardiovascular system -- Periodicals; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; Blood Circulation; Cardiovascular System; Vascular Diseases; 616.1
• DOI: 10.1161/CIRCULATIONAHA.114.014107
• Languages: English
• ISSNs: 0009-7322

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Background—</title> <p>Daily home monitoring of oxygen saturation and weight has been reported to improve outcomes for patients with single-ventricle heart disease during the period between stage I palliation and stage II palliation. However, these studies have been limited to single institutions and used historical control subjects. Our objective was to determine the association of various interstage home monitoring strategies with outcomes using a multicenter cohort with contemporary control subjects.</p> </sec> <sec> <title>Methods and Results—</title> <p>We performed a retrospective cohort study using prospectively collected data from the National Pediatric Cardiology Quality Improvement Collaborative from 2008 to 2012. We compared interstage mortality, unscheduled readmissions, and change in weight-for-age <italic>Z</italic> score for various home monitoring strategies of oxygen saturation (n=494) or weight (n=472), adjusting for sex, syndrome, tricuspid regurgitation, arch obstruction, and shunt type. Overall interstage mortality was 8.1%, and 47% had ≥1 unscheduled readmission. We did not find any associations of home oxygen saturation or weight monitoring with mortality or readmission. Although there was no difference in weight-for-age <italic>Z</italic> score for daily (0.33±0.12) versus weekly (0.34±0.18, <italic>P</italic>=0.98) weight monitoring, daily home weight monitoring was superior to no home weight monitoring (−0.15±0.18; <italic>P</italic><0.01).</p> </sec> <sec> <title>Conclusions—</title> <p>Home weight monitoring is associated with improved weight gain during the interstage period, but we did not find any benefits in other clinical outcomes for either home oxygen saturation monitoring or home weight monitoring.</p> </sec> </abstract>